Global Clinical Trial Imaging Market Based on Product and Service (Services, Software), By Based on Modality (Ultrasound, X-ray, Echocardiography), By Application (Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Introduction

Various imaging technologies are used in clinical trial imaging to examine internal body parts, which are further used to observe drug activities within the body. This process provides a detailed, precise, and rapid scan of the body and subsequent drug reactions. Medical imaging has a vital role in clinical trials, as it resolves several issues related to the drug development process by using primary, quantitative, and surrogate biomarkers.

This decreases the attrition rate during the later stages of drug development, moreover, it aids in gathering critical information about safety, efficacy, and action mechanisms during pre-clinical trial stages.

Medical imaging has several applications in pharmaceutical clinical trials such as identifying disease predisposition, diagnosing and evaluating lesions and their severity, determining the responder patients, and monitoring therapy effects as well as their follow-ups. Positron Emission Tomography (PET), a branch of nuclear imaging, coupled with observation of specific molecular endpoints is used to monitor drug pharmacokinetics and distribution.

Request Covid - 19 Impact

Detailed Segmentation

Based on Product and Service:

• Services
  • Operational Imaging Services
  • Read Analysis Services
  • System and Technical Support Services
  • Trial Design & Consulting Services
• Software

Based on Modality:

• Computed Tomography
• Magnetic Resonance Imaging
• Ultrasound
• Positron Emission Tomography
• X-ray
• Echocardiography

Based on the Therapeutic area

• Oncology
• Infectious Diseases
• Neurology
• CVS
• Endocrinology
• Immunological Disorders

Based on End-User

• Pharmaceutical Companies
• Biotechnology Companies
• Medical Device Manufacturer
• Contract Research Organizations

Based on Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Market Dynamics

Drivers for the Global Clinical Trial Imaging Market:

An increase in investments towards R&D activities aimed at the development of drugs, breakthrough molecules, etc., coupled with a greater focus on projects to develop new diagnostics and therapeutic products, as well as increasing government support and aid in both developed and developing nations towards life-science projects and drug development are major factors that are anticipated to augment revenue prospects for this global market.

Restraints Global Clinical Trial Imaging Market:

The high cost of medical imaging equipment, coupled with its greater installation and costs are factors hindering the economic growth of clinical trial imaging in the pharmaceutical industry. Moreover, a lack of skilled professionals is another factor limiting the financial trajectory of this given market.

Opportunities for the Global Clinical Trial Imaging Market:

The lower costs of clinical trial imaging in developing nations such as China, India, South Korea, Brazil, and Mexico, among others, paired with the evolving medical capabilities of these nations are primary factors that could potentially create lucrative revenue growth opportunities for this market over the forecast period.

Trends for the Global Clinical Trial Imaging Market:

The increasing support and aid from governments of both developed and developing nations such as the US, the UK, China, India, Brazil, and South Korea, among others. This aforementioned factor coupled with a shift in the focus of prominent industry players towards the additional development of drugs, and the need to secure EMA and FDA approvals are trends that are expected to further have a positive influence on this market’s revenue trajectory prospects.

Competitive Landscape

• ICON PLC.
• BioTelemetry Inc.
• Biomedical Systems Corporation
• Medpace Holdings Inc.
• IXICO PLC.
• Resonance Health Ltd.
• Radiant Sage LLC.
• BioClinica Inc.
• Intrinsic Imaging LLC.
• Cardiovascular Imaging Technologies LLC.
• Medical Metrics Inc.
• Prism Clinical Imaging Inc.
• Boston Imaging Core Lab LLC.
• anagram 4 clinical trials
• Lyscaut Medical Imaging Company
• Calyx Group
• Bioseptive Inc.
• ProScan Imaging LLC.
• Micron Inc.
• Imaging Endpoints LI LLC
• Perspectum Ltd.
•  Pharmtrace klinische Entwicklung GmbH
•  WorldCare Clinical LLC

For the Clinical Trial Imaging Market research study, the following years have been considered to estimate the market size: